Area of research
Nephrology · Pathology and Forensic Medicine
Research interest
Research focused on Albuminuria and Urology, with related work in Placebo, Type 2 diabetes, Paricalcitol. Notable publications include 'Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial', 'Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease', and 'The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy'.
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy
Baseline characteristics and enrichment results from the <scp>SONAR</scp> trial
Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy
The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease
Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD)